The European Union is ordering U.S. biotech giant Illumina to undo its $7.1 billion purchase of cancer-screening company Grail because it closed the deal without approval of regulators
Source: EU orders biotech giant Illumina to unwind $7.1 billion purchase of cancer-screening company Grail
Category: International
